Detalhe da pesquisa
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754055
2.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705160
3.
Letting the mantle out of the bag.
Br J Haematol
; 204(1): 11-13, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880826
4.
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
Blood
; 140(17): 1907-1916, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789260
5.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721751
6.
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.
Ann Hematol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630129
7.
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
Br J Haematol
; 203(2): 244-254, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584198
8.
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations.
Hematol Oncol
; 41(1): 3-15, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251481
9.
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.
Hematol Oncol
; 41(1): 16-25, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238977
10.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265128
11.
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
Br J Haematol
; 199(4): 507-519, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945164
12.
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine.
Haematologica
; 107(4): 790-802, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045693
13.
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement.
Hematol Oncol
; 40(3): 332-340, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212014
14.
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement.
Hematol Oncol
; 40(4): 518-527, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247223
15.
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper.
Hematol Oncol
; 40(4): 505-517, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488888
16.
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Hematol Oncol
; 40(4): 609-616, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612350
17.
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
Br J Haematol
; 192(6): 1011-1014, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410259
18.
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Blood
; 134(20): 1708-1711, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570488
19.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Blood
; 134(10): 798-801, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292118
20.
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
Haematologica
; 106(4): 1120-1128, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273478